Mind Medicine Inc (NASDAQ: MNMD) on Monday, plunged -5.74%% from the previous trading day, before settling in for the closing price of $7.05. Within the past 52 weeks, MNMD’s price has moved between $4.70 and $10.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 12.11% over the past five years. The company achieved an average annual earnings per share of 5.67%. With a float of $72.82 million, this company’s outstanding shares have now reached $75.51 million.
Let’s look at the performance matrix of the company that is accounted for 74 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mind Medicine Inc (MNMD) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mind Medicine Inc is 3.61%, while institutional ownership is 54.05%. The most recent insider transaction that took place on Mar 25 ’25, was worth 142,942. In this transaction Chief Executive Officer of this company sold 21,208 shares at a rate of $6.74, taking the stock ownership to the 856,556 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Chief Medical Officer sold 6,836 for $6.74, making the entire transaction worth $46,075. This insider now owns 446,177 shares in total.
Mind Medicine Inc (MNMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 5.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.97% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Mind Medicine Inc (MNMD) is currently performing well based on its current performance indicators. A quick ratio of 7.27 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.04, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.55 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Mind Medicine Inc (NASDAQ: MNMD) saw its 5-day average volume 1.24 million, a negative change from its year-to-date volume of 1.59 million. As of the previous 9 days, the stock’s Stochastic %D was 23.83%.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 33.82%, which indicates a significant increase from 16.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.40% in the past 14 days, which was lower than the 80.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.71, while its 200-day Moving Average is $6.79. Nevertheless, the first resistance level for the watch stands at $6.94 in the near term. At $7.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.54. If the price goes on to break the first support level at $6.34, it is likely to go to the next support level at $6.04. The third support level lies at $5.74 if the price breaches the second support level.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
Market capitalization of the company is 502.05 million based on 75,553K outstanding shares. Right now, sales total 0 K and income totals -108,680 K. The company made 0 K in profit during its latest quarter, and -23,350 K in sales during its previous quarter.
